Trial Profile
Pivotal phase III programme for bepotastine and bepotastine/corticosteroid nasal sprays
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 03 May 2012
Price :
$35
*
At a glance
- Drugs Bepotastine (Primary) ; Bepotastine/corticosteroid (Primary)
- Indications Seasonal allergic rhinitis
- Focus Registrational; Therapeutic Use
- 03 May 2012 New trial record